NCT01449201View on ClinicalTrials.gov

PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

March 31, 2014

Conditions
Head Neck Cancer Squamous Cell MetastaticHead Neck Cancer Squamous Cell Recurrent
Interventions
DRUG

PF-00299804

45 mg P.O. Daily (28-day treatment as one treatment cycle)

Trial Locations (6)

120-752

Severance Hospital, Seoul

Unknown

Chilgok Kyungpook National University Hospital, Daegu

Dongsan Medical Center, Daegu

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital Cancer Center, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01449201 - PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter